Inside Immatics / Scientific Advisory Board

Scientific Advisory Board

Immatics’ Scientific Advisory Board is made up of pioneering scientists with
expertise ranging across areas such as immuno-oncology, adoptive cell therapies,
clinical oncology and cancer biology.

Cassian Yee, M.D.

MD Anderson Cancer Center US
Crystal Mackall, M.D.

Co-Chair
Stanford University US
Dirk Busch, Prof. Dr. med.

Technical University of Munich Germany
Gwendolyn Binder, Ph.D.

Cabaletta Bio US
Hans-Georg Rammensee, Ph.D.

Eberhard Karls University Germany
Hidde Ploegh, Ph.D.

Boston Children’s Hospital US
Patrick Hwu, M.D.

Co-Chair Moffitt Cancer Center US
Roland Kontermann, Ph.D.

University of Stuttgart Germany